CORMEDIX ALERT: Bragar Eagel & Squire, P.C. is Investigating CorMedix Inc. on Behalf of CorMedix Stockholders and Encourages Investors to Contact the Firm

Stock Information for Arch Therapeutics Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Arch Therapeutics Inc

CorMedix inc. Announces Customer Implementation
CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference
CorMedix Inc. to Participate in the RBC Global Healthcare Conference
CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025
Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance
CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
Kirby McInerney LLP Announces Investigation Against CorMedix Inc. (CRMD) on Behalf of Investors

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.